IDBiologics

Nashville, United States

IDBiologics is a human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases.

$500K raised

May 2023

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has IDBiologics raised?

IDBiologics has raised $500K in total funding. The most recent round was Seed. The last funding was announced in May 2023.

Who are IDBiologics's investors?

IDBiologics's investors include Launch Tennessee, Acequia Capital (AceCap), Vanderbilt University, Flying Point Industries.

Where is IDBiologics headquartered?

IDBiologics is headquartered in Nashville, United States.

What does IDBiologics do?

IDBiologics is a human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases.

What stage is IDBiologics at?

IDBiologics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 23, 2023.

MLA

"IDBiologics — Funding & Investors." VCBacked, May 23, 2023, https://www.vcbacked.co/company/idbiologics. Accessed July 2, 2026.

APA

VCBacked. (2023). IDBiologics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/idbiologics

Wikipedia (cite web)

{{cite web |title=IDBiologics — Funding & Investors |url=https://www.vcbacked.co/company/idbiologics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 23, 2023.